Concepedia

D. A. Evseev

DA

Statistics

Publications

10

Citations

555

H-Index

10

Active since

2017

Affiliations

Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology(Current)

University Hospital in Motol

University Medical Center Freiburg

Princess Máxima Center

Stanford University

D. A. Evseev is an author at Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology specializing in medicine, pediatric hematology, and oncology.

ORCID

Publications per year

2017–2023

10

Publications

10

Vemurafenib for Refractory Multisystem Langerhans Cell Histiocytosis in Children: An International Observational Study

Jean Donadieu, Islam Amine Larabi, M. Tardieu et al. · Journal of Clinical Oncology · 2019 · 220 citations · Full text

, , +13

ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition

Paul G. Kemps, Jennifer Picarsic, Benjamin H. Durham et al. · Blood · 2021 · 155 citations · Full text

, , +17

Efficacy of combined immunosuppression with or without eltrombopag in children with newly diagnosed aplastic anemia

G. А. Novichkova, T. Yu. Salimova, Dina Baidildina et al. · Blood Advances · 2022 · 37 citations · Full text

, , +16

Vemurafenib combined with cladribine and cytarabine results in durable remission of pediatric BRAF V600E–positive LCH

D. A. Evseev, D. S. Osipova, Anna Ignatova et al. · Blood Advances · 2023 · 29 citations · Full text

, , +9

Vemurafenib provides a rapid and robust clinical response in pediatric Langerhans cell histiocytosis with the BRAF V600E mutation but does not eliminate low-level minimal residual disease per ddPCR using cell-free circulating DNA

D. A. Evseev, D. S. Osipova, Anna Ignatova et al. · International Journal of Hematology · 2021 · 28 citations

, , +14

1–5 of 10